Kristofer Svensson

Director of Finance/CFO presso GABATHER AB

Health Technology

Consumer Services

Electronic Technology

Profilo

Kristofer Svensson currently works at Gabather AB, as Chief Financial Officer, Bioextrax AB, as Chief Financial Officer from 2023, Sinfonia Biotherapeutics AB, as Chief Financial Officer from 2022, Ectin Research AB, as Chief Financial Officer, and Melius Pharma AB, as Chief Financial Officer from 2022.
Mr. Svensson also formerly worked at Sensidose AB, as Chief Financial Officer from 2017 to 2022.
Mr. Svensson received his graduate degree from the University of Stockholm.

Posizioni attive di Kristofer Svensson

Società	Posizione	Inizio
GABATHER AB	Director of Finance/CFO	-
BIOEXTRAX AB	Director of Finance/CFO	01/01/2023
ECTIN RESEARCH AB	Director of Finance/CFO	-
Melius Pharma AB Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients.	Director of Finance/CFO	01/05/2022
Sinfonia Biotherapeutics AB Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a Swedish clinical stage company that develops biologics for neuropathic pain. The private company is based in Huddinge, Sweden.	Director of Finance/CFO	01/01/2022

Tutte le posizioni attive di Kristofer Svensson

Precedenti posizioni note di Kristofer Svensson

Società	Posizione	Fine
SENSIDOSE AB	Director of Finance/CFO	01/10/2022

Vedi nel dettaglio l'esperienza di Kristofer Svensson

Formazione di Kristofer Svensson

University of Stockholm

Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Kristofer Svensson

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	4
GABATHER AB	Health Technology
ECTIN RESEARCH AB	Health Technology
SENSIDOSE AB	Electronic Technology
BIOEXTRAX AB	Health Technology

Aziende private	2
Sinfonia Biotherapeutics AB Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a Swedish clinical stage company that develops biologics for neuropathic pain. The private company is based in Huddinge, Sweden.	Health Technology
Melius Pharma AB Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients.	Health Technology